Burke, Kristin E.
Nayor, Jennifer
Campbell, Emily J.
Ananthakrishnan, Ashwin N.
Khalili, Hamed
Richter, James M.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (F32 DK115134, K23 DK099681)
American Gastroenterological Association (HK)
Article History
Received: 20 March 2019
Accepted: 19 July 2019
First Online: 1 August 2019
Compliance with Ethical Standards
:
: Kristin E. Burke, Jennifer Nayor, and Emily J. Campbell have no conflicts of interest to disclose. Ashwin N. Ananthakrishnan served on the scientific advisory board of Abbvie, Takeda, and Merck. Hamed Khalili receives consulting fees from Abbvie, Takeda, and Samsung Bioepis. James M. Richter is a consultant for Shire Pharmaceuticals.
: This study was approved by the Massachusetts General Hospital Institutional Review Board.